Juvenescence Raises $100M To Advance Anti-Aging Programs

 
• By Scrip Team

The financing, which brings the total raised by Juvenescence to $165m, comes as longevity R&D programs supported by the company move towards human testing.

Age_100
Juvenescence backing longevity start-ups • Source: Shutterstock

More from Financing

More from Business